The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-vascular endothelial growth factor therapy (anti-VEGF) for non-infectious macular edema in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Diabetic Macular Edema Treatments in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-vascular endothelial growth factor (anti-VEGF) diabetic macular Edema treatments in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also s...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antithrombin Therapeutics in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antithrombin therapeutics in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In ord...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antiulcerant Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antiulcerant drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to m...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Snoring Treatments in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-snoring treatments in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Snoring Devices in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-snoring devices in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Smoking Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-smoking drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to m...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antiseptics and Disinfectants in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antiseptics and disinfectants in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antisense and RNAi Therapeutics in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antisense and RNAi therapeutics in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antiseptic First Aid Creams, Sprays, and Wipes in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antiseptic first aid creams, sprays, and wipes in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. gr...
11/28/2022 | Japan Outlook 2023
